Paul M Bingham

1PUBLICATIONS
0CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 08, 2022
Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613.

Moises O Guardado Rivas, Shawn D Stuart, Daniel Thach

Pageof 1

Frequent Collaborators